HST-NEETs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HST-NEETs, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 [Phase 2]